Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Artocarpus heterophyllus seed extract may help treat prostate inflammation without side effects.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Finasteride doesn't change rat testicle weight or sperm production.

International medical graduates outperformed U.S. graduates on an internal medicine exam.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Physical activity, height, and smoking affect prostate cancer risk.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Vertex pattern hair loss linked to higher prostate cancer risk.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

The transscrotal testosterone patch normalizes hormone levels in men with AIDS and weight loss but does not improve weight, body mass, or quality of life.

Vitamin D may help regulate cholesterol and influence prostate cancer development.

Obesity is linked to more severe lower urinary tract symptoms.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Balding and low testosterone increase risk of urinary stones.

Male pattern baldness does not cause an increased risk of prostate cancer.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.